Home » Newsletters » BioWorld Asia

BioWorld Asia

April 5, 2000

View Archived Issues

MediGene, Schering Align In $52M Deal For HPV Vaccine

Researchers Identify Peptide That Triggers Celiac Disease

Celltech Buys U.S.-Based Cistron, Gains Access To IL-1 Technology

November AG Taking Program Public On Market In Germany

SR Pharma Sees Additional Positive Data From SRL172

Mologen Starts Phase II/III Cancer Gene Therapy Trial

Israeli Researchers Show Toxic Shock Antidote Works In Mice

Australian Stocks Doing Well, But Lag Behind U.S. Counterparts

Peptide Therapeutics In Talks With Potential Company Buyer

Transghne Obtains U.S. Patent Covering Adenovirus Technique

DevCo Licenses Lexipafant, Marking Third Deal In A Month

Cambridge Antibody Raises #90M In Scaled-Back Offering

Teva To Market Bio-Tropin As Part Of $20M BTG Deal

Other News To Note

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...